Average Co-Inventor Count = 3.34
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (12 from 1,535 patents)
2. Boehringer Ingelheim Pharmaceuticals, Inc. (5 from 276 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
17 patents:
1. 8519176 - Process for preparation of substituted P-aminophenol
2. 8362035 - Crystalline forms of a potent HCV inhibitor
3. 8232293 - Crystalline forms of a potent HCV inhibitor
4. 8222369 - Process for preparing macrocyclic compounds
5. 8212049 - Electronically tuned ligands for asymmetric hydrogenation
6. 8101765 - Process for preparing acyclic HCV protease inhibitors
7. 8017771 - Process for preparing acyclic HCV protease inhibitors
8. 7994335 - Electronically tuned ligands for asymmetric hydrogenation
9. 7608614 - Process for preparing macrocyclic compounds
10. 7544798 - Process for preparing macrocyclic compounds
11. 7514557 - Process for preparing acyclic HCV protease inhibitors
12. 7491851 - Method for generating secondary phosphines
13. 7309700 - Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3′-e] [1,4]diazepin-6-one
14. 7256314 - Method for generating secondary phosphines
15. 7186827 - Dipeptide synthesis